GENI.STGENI.STSTO
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +23.73% | +6.31% | +2.06% | +5.29% | +2.99% |
| Gross Profit Growth | +107.16% | +82.10% | +20.53% | +12.94% | -28.37% |
| EBITDA Growth | +58.28% | +36.88% | +36.30% | +15.87% | -15.55% |
| Operating Income Growth | +66.25% | +41.05% | +33.60% | +15.20% | -10.74% |
| Net Income Growth | +64.34% | +38.53% | +33.46% | +14.17% | -12.88% |
| EPS Growth | +64.44% | +40.00% | +31.82% | +13.79% | -12.16% |
| EPS Diluted Growth | +64.44% | +40.00% | +31.82% | +13.79% | -12.16% |
| Weighted Average Shares Growth | +0.00% | +0.00% | +0.00% | -0.00% | -0.00% |
| Weighted Average Shares Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +13.25% | -34.09% | +0.00% | -13.28% | +66.63% |
| Free Cash Flow Growth | +11.92% | -37.63% | +0.00% | +28.04% | +78.95% |
| Receivables Growth | +23.51% | +28.00% | -0.58% | +3.83% | +5.45% |
| Inventory Growth | -30.12% | +18.08% | +50.90% | +61.22% | +49.62% |
| Asset Growth | +14.92% | +11.50% | +17.84% | +19.82% | +18.17% |
| Book Value per Share Growth | +18.99% | +21.08% | +29.62% | +27.22% | +20.59% |
| Debt Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | +269.01% | +0.00% | +0.00% | +0.00% | -100.00% |
| SG&A Expenses Growth | -20.32% | -3.85% | -100.00% | -100.00% | -100.00% |